Type 3 Innate Lymphoid Cell-Derived Lymphotoxin Prevents Microbiota-Dependent Inflammation

Yuan Zhang,Tae-Jin Kim,Joanna A Wroblewska,Vera Tesic,Vaibhav Upadhyay,Ralph R Weichselbaum,Alexei V Tumanov,Hong Tang,Xiaohuan Guo,Haidong Tang,Yang-Xin Fu

DOI: https://doi.org/10.1038/cmi.2017.25

2017-01-01

Cellular and Molecular Immunology

Abstract:Splenomegaly is a well-known phenomenon typically associated with inflammation. However, the underlying cause of this phenotype has not been well characterized. Furthermore, the splenomegaly phenotype seen in lymphotoxin (LT) signaling-deficient mice is characterized by increased numbers of splenocytes and splenic neutrophils. Splenomegaly, as well as the related phenotype of increased lymphocyte counts in non-lymphoid tissues, is thought to result from the absence of secondary lymphoid tissues in LT-deficient mice. We now present evidence that mice deficient in LTα 1 β 2 or LTβR develop splenomegaly and increased numbers of lymphocytes in non-lymphoid tissues in a microbiota-dependent manner. Antibiotic administration to LTα 1 β 2 - or LTβR-deficient mice reduces splenomegaly. Furthermore, re-derived germ-free Ltbr −/− mice do not exhibit splenomegaly or increased inflammation in non-lymphoid tissues compared to specific pathogen-free Ltbr −/− mice. By using various LTβ- and LTβR-conditional knockout mice, we demonstrate that retinoic acid-related orphan receptor γT-positive type 3 innate lymphoid cells provide the required active LT signaling to prevent the development of splenomegaly. Thus, this study demonstrates the importance of LT-mediated immune responses for the prevention of splenomegaly and systemic inflammation induced by microbiota.